Dublin, Oct. 06, 2016 -- Research and Markets has announced the addition of the "Flow Cytometry: Products, Technologies and Global Markets" report to their offering.
The global market for flow cytometry products should reach over $6.3 billion by 2020 from nearly $4.1 billion in 2015 at a compound annual growth rate (CAGR) of 9.1% from 2015 to 2020.
New product introductions launched since 2013 are covered. Due to the timing of the writing of this report, the figures for 2015 are estimated except where actual results have been reported.
This report provides:
- An overview of flow cytometry products, technologies, and global markets.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Breakdowns of the flow cytometry market into segments such as instruments, reagents, software, services, technologies, applications, and end users.
- Discussions of how constraints such as increased equipment costs are hindering market growth.
- Intensive analysis with respect to top innovations, key market players and opportunities.
- Profiles of major players in the industry.
The key contents of the report are:
- Key market analysis.
- Strategic recommendations.
- Market dynamics.
- Market estimation for the forecast period of 2015 through 2020.
- Competitive developments.
- Profiles of key market players.
- Patents.
Key Topics Covered:
Chapter 1: Introduction
- Study Background
- Study Goals And Objectives
- Intended Audience
- Scope And Format
- Research Methodology And Information Sources
- Analyst's Credentials
Chapter 2: Summary
Chapter 3: Market Overview
- Current Market Dynamics
- Outlook Through Forecast Period
- Market Drivers
- Opportunities
- Evolution Of Flow Cytometry
- Analysis Of Flow Cytometry's Capabilities
- Acquisition Summary And Market Implications
- Analyses: Key Players, Competitors And Market
- Emerging Economies And Technology Adoption
- Strategic Recommendations
- Patent Analysis
Chapter 4: Global Market For Flow Cytometry Products
- Market For Flow Cytometry Instruments
- Market Drivers
- Market Restraints
- Cytometry Platforms
- Replaceable Components
- Flow Cytometry Accessories
- Market For Flow Cytometry Reagents And Consumables
- Software Market
- Services
Chapter 5: Global Market For Applications Of Flow Cytometry
- Market Drivers
- Market Restraints
- Research Applications
- Clinical Applications
Chapter 6: Global Market For Flow Cytometry Technology
- Flow Cytometry Technology
- Cell-Based Flow Cytometry
- Bead-Based Flow Cytometry
Chapter 7: Flow Cytometry End-User Market
- Flow Cytometry End-User Market
- Commercial Organizations
- Academic Institutions
- Hospitals
- Medical Schools And Clinical Testing Labs
- Others
Chapter 8: Competitive Landscape
- Recent Flow Cytometry Industry Developments
Chapter 9: Geographic Analysis Of The Global Flow Cytometry Market
- Europe
- United States
- Asia And ROW
Chapter 10: Company Profiles
- Acea Biosciences Inc.
- Advanced Cell Diagnostics
- Agilent Technologies
- Alpco Diagnostics
- Apogee Flow Systems
- Applied Cytometry
- Bangs Laboratory Inc.
- Beckman Coulter (Danaher)
- Becton, Dickinson And Co.
- Biocytex
- Biolegend
- Bio-Rad
- Biostatus
- Bio-Techne Corp.
- Biovision Inc.
- Cell Signaling Technology
- Coherent Inc.
- Cytek Development Inc.
- Cytobuoy Bv
- Cytonome
- Dako (Agilent Technologies)
- De Novo Software
- Dharmacon (Ge Life Sciences)
- Dvs Sciences
- Ebioscience (Affymetrix)
- Emd Millipore (Merck/Milliporesigma)
- Flowjo Llc
- Fluidigm
- Fluorofinder
- Hamamatsu Photonics K.K.
- Icyt Mission Technology Inc.
- Inivai Technologies
- Intellicyt Corp.
- Intrexon
- Invitrogen (Thermo Fisher Scientific)
- Luminex Corp.
- Materion Precision Coatings (Materion Corp.)
- Melles Griot (Idex Optics And Photonics)
- Milliporesigma (Merck)
- Miltenyi Biotec
- Nanocellect Biomedical Inc.
- Omega Optical Inc.
- On-Chip Biotechnologies Co. Ltd.
- Partec Gmbh
- Pointcare Technologies Inc.
- Promega Corp.
- Quantacyte
- R&D Systems Inc
- Santa Cruz Biotechnology Inc.
- Semrock Inc. (Idex Health & Science Llc)
- Sigma-Aldrich Corp. (Merck/Milliporesigma)
- Sirigen (Becton Dickinson)
- Sony Biotechnology Inc.
- Southern Biotech
- Spherotech Inc.
- Stratedigm Inc
- Sysmex Partec Gmbh
- Tonbo Biosciences
- Tree Star
- Union Biometrica Inc.
- Verity Software House
Chapter 11: U.S. Patents And Patent Applications
For more information about this report visit http://www.researchandmarkets.com/research/x2lr5d/flow_cytometry
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



